Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Carlsbad, CA
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Fort Myers, FL
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Mount Pleasant, SC
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
San Antonio, TX
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
New Orleans, LA
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Investigator Site
mi
from
Saint Louis, MO
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Investigator Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Omaha, NE
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Combination of Lenalidomide and Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL)
Status: Enrolling
Updated:  12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Combination of Lenalidomide and Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL)
Status: Enrolling
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Interventional Bioremediation of Microbiota in Metabolic Syndrome
Interventional Bioremediation of Microbiota in Metabolic Syndrome
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Interventional Bioremediation of Microbiota in Metabolic Syndrome
Interventional Bioremediation of Microbiota in Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients
A Phase 2 Proof-of-Concept Study of Sensor-Guided, Clinician-Administered Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Post-Prandial Hypoglycemia in Post-Bariatric Surgery Patients
Status: Enrolling
Updated:  12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients
A Phase 2 Proof-of-Concept Study of Sensor-Guided, Clinician-Administered Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Post-Prandial Hypoglycemia in Post-Bariatric Surgery Patients
Status: Enrolling
Updated: 12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Young Adults
Pilot Study to Evaluate Use of Optical Frequency Domain Imaging (OFDI) for Duodenal Imaging in Celiac Disease in Children, Adolescents and Young Adults
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Young Adults
Pilot Study to Evaluate Use of Optical Frequency Domain Imaging (OFDI) for Duodenal Imaging in Celiac Disease in Children, Adolescents and Young Adults
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of MCT in a Mixed Racial Population of Patients With Metabolic Syndrome: a Feasibility Study
Evaluation of Medium Chain Triglycerides in a Mixed Racial Population of Patients With Metabolic Syndrome: a Feasibility Study
Status: Enrolling
Updated:  12/31/1969
Boston Med Ctr
mi
from
Boston, MA
Evaluation of MCT in a Mixed Racial Population of Patients With Metabolic Syndrome: a Feasibility Study
Evaluation of Medium Chain Triglycerides in a Mixed Racial Population of Patients With Metabolic Syndrome: a Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
An Open Label Study to Evaluate the Safety and Efficacy of 12 Week Treatment With CFZ533 in Patients With Graves' Disease
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Honolulu, HI
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
An Open Label Study to Evaluate the Safety and Efficacy of 12 Week Treatment With CFZ533 in Patients With Graves' Disease
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
An Open Label Study to Evaluate the Safety and Efficacy of 12 Week Treatment With CFZ533 in Patients With Graves' Disease
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Mainz,
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
An Open Label Study to Evaluate the Safety and Efficacy of 12 Week Treatment With CFZ533 in Patients With Graves' Disease
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Mainz,
Click here to add this to my saved trials
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
An Open Label Study to Evaluate the Safety and Efficacy of 12 Week Treatment With CFZ533 in Patients With Graves' Disease
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Rochester, MN
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
An Open Label Study to Evaluate the Safety and Efficacy of 12 Week Treatment With CFZ533 in Patients With Graves' Disease
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Rochester, MN
Click here to add this to my saved trials
Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
A Phase 2a, Randomized, Multicenter, Open-Label, Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
A Phase 2a, Randomized, Multicenter, Open-Label, Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
A Phase 2a, Randomized, Multicenter, Open-Label, Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia
Status: Enrolling
Updated:  12/31/1969
Vanderbilt Medical Center Endocrinology
mi
from
Nashville, TN
Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
A Phase 2a, Randomized, Multicenter, Open-Label, Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia
Status: Enrolling
Updated: 12/31/1969
Vanderbilt Medical Center Endocrinology
mi
from
Nashville, TN
Click here to add this to my saved trials
Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
A Phase 2a, Randomized, Multicenter, Open-Label, Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia
Status: Enrolling
Updated:  12/31/1969
University of Würzburg
mi
from
Würzburg,
Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
A Phase 2a, Randomized, Multicenter, Open-Label, Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia
Status: Enrolling
Updated: 12/31/1969
University of Würzburg
mi
from
Würzburg,
Click here to add this to my saved trials
Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
A Phase 2a, Randomized, Multicenter, Open-Label, Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia
Status: Enrolling
Updated:  12/31/1969
Shriners Hospitals for Children
mi
from
Saint Louis, MO
Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
A Phase 2a, Randomized, Multicenter, Open-Label, Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia
Status: Enrolling
Updated: 12/31/1969
Shriners Hospitals for Children
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP)
Extension Study of Protocol ENB-006-09 Evaluating the Long-term Safety and Efficacy of Asfotase Alfa (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Health Sciences Centre
mi
from
Winnipeg,
Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP)
Extension Study of Protocol ENB-006-09 Evaluating the Long-term Safety and Efficacy of Asfotase Alfa (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Health Sciences Centre
mi
from
Winnipeg,
Click here to add this to my saved trials
Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP)
Extension Study of Protocol ENB-006-09 Evaluating the Long-term Safety and Efficacy of Asfotase Alfa (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated:  12/31/1969
Shriners Hospital For Children
mi
from
Saint Louis, MO
Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP)
Extension Study of Protocol ENB-006-09 Evaluating the Long-term Safety and Efficacy of Asfotase Alfa (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Children With Hypophosphatasia (HPP)
Status: Enrolling
Updated: 12/31/1969
Shriners Hospital For Children
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)
Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)
Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism
Status: Enrolling
Updated:  12/31/1969
Cook Children's Medical Center
mi
from
Fort Worth, TX
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism
Status: Enrolling
Updated: 12/31/1969
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism
Status: Enrolling
Updated:  12/31/1969
UCSF School of Medicine, Division of Pediatric Endocrinology
mi
from
San Francisco, CA
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism
Status: Enrolling
Updated: 12/31/1969
UCSF School of Medicine, Division of Pediatric Endocrinology
mi
from
San Francisco, CA
Click here to add this to my saved trials
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism
Status: Enrolling
Updated:  12/31/1969
UCLA Mattel Children's Hospital
mi
from
Los Angeles, CA
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism
Status: Enrolling
Updated: 12/31/1969
UCLA Mattel Children's Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism
Status: Enrolling
Updated:  12/31/1969
Washington University/St. Louis Children's Hospital
mi
from
Saint Louis, MO
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism
Status: Enrolling
Updated: 12/31/1969
Washington University/St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
A Phase 2 Proof-of-Concept Study of CSI-Glucagon™ (Continuous Subcutaneous Glucagon Infusion) to Prevent Hypoglycemia With Lower Intravenous Glucose Infusion Rates in Children up to One Year of Age With Congenital Hyperinsulinism
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Elkridge, MD
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Elkridge, MD
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Rochester, NY
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Rochester, NY
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Mobile, AL
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Mobile, AL
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Chandler, AZ
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Chandler, AZ
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Phoenix, AZ
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Scottsdale, AZ
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Anaheim, CA
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Greenbrae, CA
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Greenbrae, CA
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Deland, FL
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Deland, FL
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Evansville, IN
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Evansville, IN
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Henderson, NV
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Henderson, NV
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Garden City, NY
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Garden City, NY
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Great Neck, NY
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
New York, NY
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
New York, NY
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Raleigh, NC
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Nashville, TN
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Nashville, TN
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Dallas, TX
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
West Jordan, UT
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
West Jordan, UT
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Norfolk, VA
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Los Angeles, CA
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Las Vegas, NV
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Albany, NY
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Albany, NY
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Charlotte, NC
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Charlotte, NC
Click here to add this to my saved trials